|
11 |
Highly purified, highly effective cell therapy containing decidua-derived stromal cells
Registration No. : 10-2024-0032214
Registration Date : 2024.03.06
Country : Registration (Rep. of Korea)
|
10-2024-0032214 |
2024.03.06 |
Registration (Rep. of Korea) |
|
10 |
Decidual derived stromal cell population and use thereof
Registration No. : 10-2024-0032215
Registration Date : 2024.03.06
Country : Registration (Rep. of Korea)
|
10-2024-0032215 |
2024.03.06 |
Registration (Rep. of Korea) |
|
9 |
Uses of mesenchymal stem cells with enhanced ability to produce immunomodulatory factors
Registration No. : 10-1865040
Registration Date : 2018.05.31
Country : Registration (Rep. of Korea)
|
10-1865040 |
2018.05.31 |
Registration (Rep. of Korea) |
|
8 |
Composition for inducing differentiation into IL-10-producing regulatory T cells
Registration No. : 10-1518370
Registration Date : 2015.04.30
Country : Registration (Rep. of Korea)
|
10-1518370 |
2015.04.30 |
Registration (Rep. of Korea) |
|
7 |
Cell therapeutic composition for prevention or treatment of transplanted pulpit disease that comprises mesertic stem cells and immunized T cells as an active ingredient
Registration No. : 10-1578591
Registration Date : 2015.12.11
Country : Registration (Rep. of Korea)
|
10-1578591 |
2015.12.11 |
Registration (Rep. of Korea) |
|
6 |
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 20180305665
Registration Date : 2022.07.02
Country : Decision on Registration (U.S)
|
20180305665 |
2022.07.02 |
Decision on Registration (U.S) |
|
5 |
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 06697076
Registration Date : 2020.04.27
Country : Registration (Japan)
|
06697076 |
2020.04.27 |
Registration (Japan) |
|
4 |
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 10-1867942
Registration Date : 2018.06.08
Country : Registration (Rep. of Korea)
|
10-1867942 |
2018.06.08 |
Registration (Rep. of Korea) |
|
3 |
Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells
Registration No. : 14/671,626
Registration Date : 2018.12.18
Country : Registration (U.S)
|
14/671,626 |
2018.12.18 |
Registration (U.S) |
|
2 |
Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells
Registration No. : 10-1723786
Registration Date : 2017.03.31
Country : Registration (Rep. of Korea)
|
10-1723786 |
2017.03.31 |
Registration (Rep. of Korea) |
|
1 |
Mesenchymal stem cell introduced with a nucleotide sequence encoding TGFβ and use thereof
Registration No. : 10-1301262
Registration Date : 2013.08.19
Country : Registration (Rep. of Korea)
|
10-1301262 |
2013.08.19 |
Registration (Rep. of Korea) |
